Physician profile

Thomas J Gill

Sports Medicine (Orthopaedic Surgery) · Dedham, MA

NPI 1457339491

$168,259.82

in general payments reported to CMS, 2019-2025

35 companies · $23K in 2025

The $23K reported for 2025 was more than what 91% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).

See the full distribution for Sports Medicine (Orthopaedic Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$99,479.10
Food and Beverage$5,531.47
Travel and Lodging$2,708.44
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$25.08

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medical Device Business Services, INC. $95,678.72 2019-2025 Healix Knotless Peek, Dynacord, Rigidloop
Linvatec Corporation $32,413.10 2022-2024 Biobrace 23mm, Linvatec Shoulder Arthroscopy, Livatec Knee Preservation System
Depuy Synthes Products, INC. $27,697.46 2020-2024 Healix Knotless Peek, Velys
Smith+Nephew, INC. $2,915.53 2020-2024 Bone Anchors With Arthroscopic Delivery System, N/A, Stravix
Stryker Corporation $2,837.48 2019-2025 Crossfire, 1788, Hipcheck
Vericel Corporation $1,317.24 2021-2024 Maci
Depuy Synthes Sales INC. $734.67 2022-2025 Dynacord, Rigidloop, Bristow Latarjet
Exactech, INC. $506.22 2023-2025
Zimmer Biomet Holdings, INC. $450.17 2019-2023 Juggerknotless Soft Anchor, Tapestry, Allthread
Vertex Pharmaceuticals Incorporated $366.04 2024-2025
Pacira Pharmaceuticals Incorporated $323.61 2021-2025 Exparel, Zilretta, Iovera
Anika Therapeutics, INC. $265.69 2020-2022
Nuvasive, INC. $251.17 2021
Conmed Corporation $236.77 2023 Biobrace 23mm
Kairos Surgical INC $194.22 2024
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Wright Medical Technology, INC. $189.25 2019
Integrity Implants INC. $186.36 2022
Orthofix Medical, INC. $179.72 2021-2023 Physio-Stim
Miach Orthopaedics, INC. $170.50 2022
Catalyst Orthoscience $168.30 2025
Integrity Implants INC. Dba Accelus $149.84 2023
Acumed LLC $145.59 2021
Bone Support INC. $130.33 2020
Arthrex, INC. $126.47 2019
Pacira Therapeutics, INC. $121.00 2019-2021
Avanos Medical $116.79 2021
Bioventus LLC $111.20 2020-2025 Xcell
Cerapedics INC. $102.73 2022
Derma Sciences, INC. $45.03 2019
Djo, LLC $34.99 2019
Convatec INC. $34.04 2019-2024
Medtronic, INC. $19.30 2025 Intellis Adaptivestim
Abbvie INC. $15.80 2025
Ferring Pharmaceuticals INC. $12.32 2019
Pfizer INC. $12.17 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas J Gill

$168,259.82

in general payments reported 2019-2025

Years
2019-2025
Top company
Medical Device Business Services, INC.
Context
The $23K reported for 2025 was more than what 91% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).

https://glasscript.com/doctor/21038/thomas-j-gill

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.